Skip to content

Collins Helen Louise

Reporting owner on Forms 3, 4 and 5, CIK 1701247.

Collins Helen Louise reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-19.

Issuers

IssuerRoles in the latest filingFilingsLast filed
ELVN · Enliven Therapeutics, Inc.CIK 1672619officer (CHIEF MEDICAL OFFICER)22026-11-19

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
ELVN · Enliven Therapeutics, Inc.Common Stock2026-11-17M exercised+5,000$2.4830,000Form 4
ELVN · Enliven Therapeutics, Inc.Common Stock2026-11-17S sold-4,939$46.831325,061Form 4
ELVN · Enliven Therapeutics, Inc.Common Stock2026-11-17S sold-61$47.595425,000Form 4
ELVN · Enliven Therapeutics, Inc.Stock Option (right to buy), derivative2026-11-17M exercised-5,000$096,268Form 4
ELVN · Enliven Therapeutics, Inc.Common Stock2026-10-19M exercised+5,000$2.4830,000Form 4
ELVN · Enliven Therapeutics, Inc.Common Stock2026-10-19S sold-5,000$38.468425,000Form 4
ELVN · Enliven Therapeutics, Inc.Stock Option (right to buy), derivative2026-10-19M exercised-5,000$0101,268Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0001701247-26-000015 Enliven Therapeutics, Inc.2026-11-19
Form 4 0001701247-26-000014 Enliven Therapeutics, Inc.2026-10-21